The Enterprise Value as of September 2024 (TTM) for BELLUS Health Inc. (BLU) is 1.64B

According to BELLUS Health Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.64B. This represents a change of -49.69% compared to the average of 3.26B of the last 4 quarters.

BELLUS Health Inc. (BLU) Historical Enterprise Value (quarterly & annually)

How has BLU Enterprise Value performed in the past?

The mean historical Enterprise Value of BELLUS Health Inc. over the last ten years is 465.86M. The current 1.64B Enterprise Value has changed 35.13% with respect to the historical average. Over the past ten years (40 quarters), BLU's Enterprise Value was at its highest in in the June 2023 quarter at 5.80B. The Enterprise Value was at its lowest in in the December 2021 quarter at -149207000.00.

BELLUS Health Inc. (BLU) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BELLUS Health Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BELLUS Health Inc. (BLU) Average Enterprise Value

How has BLU Enterprise Value performed in the past?

The current Enterprise Value of BELLUS Health Inc. (BLU) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BELLUS Health Inc. (BLU) Enterprise Value vs. Peers

How is BLU’s Enterprise Value compared to its peers?

BELLUS Health Inc.’s Enterprise Value is greater than Terns Pharmaceuticals, Inc. (458.36M), greater than Amylyx Pharmaceuticals, Inc. (89.50M), greater than Acumen Pharmaceuticals, Inc. (93.64M), greater than Inozyme Pharma, Inc. (343.89M), greater than X4 Pharmaceuticals, Inc. (40.79M), greater than KalVista Pharmaceuticals, Inc. (506.03M), less than Crinetics Pharmaceuticals, Inc. (3.78B), greater than Theseus Pharmaceuticals, Inc. (138.26M), greater than Kura Oncology, Inc. (1.45B), greater than Viridian Therapeutics, Inc. (813.50M), less than Biomea Fusion, Inc. (0), greater than Stoke Therapeutics, Inc. (153.42M), greater than Akero Therapeutics, Inc. (586.20M), greater than Homology Medicines, Inc. (1.56B), greater than Gossamer Bio, Inc. (-103303255.00), greater than Cytokinetics, Incorporated (317.87M), less than DICE Therapeutics, Inc. (6.96B), less than Edgewise Therapeutics, Inc. (2.21B), greater than Karuna Therapeutics, Inc. (1.60B), less than Dyne Therapeutics, Inc. (12.43B), less than null (2.73B),

Build a custom stock screener for BELLUS Health Inc. (BLU) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BELLUS Health Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BELLUS Health Inc. (BLU) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BELLUS Health Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.